Experiences in adjuvant and neoadjuvant therapy of potentially curative resected recurrent colorectal carcinoma;Erfahrungen in der adjuvanten und neoadjuvanten therapie kolorektaler karzinome mit potentiell kurativer rezidivoperation

Tumor Diagnostik und Therapie

Volumn 18, Issue 4, 1997, Pages 107-111

  Heckmann, K ^a,b   Hartung, G ^a   Manegold, K ^a   Queisser W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

5 Fluorouracil; Adjuvant treatment; Colon cancer; Folinic acid; Rectal cancer; Resection of hepatic metastases

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLON CARCINOMA; COLORECTAL CARCINOMA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MALE; RECTUM CARCINOMA;

EID: 0030776702     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Winawer S J: Diagnosis and prevention of gastrointestinal malignancies. Semin Oncol Vol 18, Suppl 1 (1991) 7-16
2. Blumgart L H, Fong Y: Surgical options in the treatment of hepatic metastasis from colorectal cancer. Surgery 32 (1995) 335-421
3. Windle R, Bell P R F, Shaw D: Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisol in colorectal cancer. Br. J. Surg. 74 (1987) 569-572
4. Hartung G, Diezler P, Hagmüller E, Queißer W: New approaches to adjuvant therapy of colorectal carcinoma including current German activities. Onkologie 16 (1993) 416-424
5. Moertel C G, Fleming T R, MacDonald J S, Haller D G, Laurie J A, Goodman P J et al.: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322 (1990) 352-358
6. Krook J E, Moertel C G, Gunderson L L, Wieand H S, Collins R T, Beart R W et al.: Effective surgical adjuvant therapy for high risk rectal carcinoma. N. Engl. J. Med. 324 (1991) 709-715
7. Kaplan E L, Meier P: Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
8. Jatzko G R, Lisborg P H, Stettner H M, Klimpfinger M H: Hepatic resection for metastases from colorectal carcinoma - A survival analysis. Eur. J. Can. 31 a (1995) 41-46
9. Rosen C B, Nagorney D M, Taswell H F, Helgeson S L, Ilstrup D M, v. Heerden J A et al.: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann. Surg. 216 (1992) 493-505
10. Hughes K S, Simon R, Songhorabodi S, Adson M A, Ilstrup D M, Fortner J G: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Surgery 103 (1988) 278-288
11. Adson M A, van Heerden J A, Adson M H, WagnerJ S, Ilstrup M S: Resection of hepatic metastases from colorectal cancer. Arch. Surg. 119 (1984) 647-651
12. Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J. Surg. 19 (1995) 59-71
13. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br. J. Surg. 77 (1990) 1241-1246
14. Rosen C B, Nagorney D M, Taswell H F, Helgeson S L, Ilstrup D M, van Heerden J A et al.: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann. Surg. 216 (1992) 493-505
15. Nordlinger B, Parc R, Delva E, Quilichini M A, Hannoun L, Huguet C: Hepatic resection of colorectal liver metastases. Ann. Surg. 205 (1987) 256-263
16. Schlag P, Hohenberger P, Hölting T, Buhl K, Schwarz V, Herfarth C: Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Eur. J. Surg. Oncol. 16 (1990) 99-104
17. Ringe B, Bechstein W O, Raab R, Meyer H J, Pichlmayr R: Leberresektion bei 157 Patienten mit kolorektalen Metastasen. Chirurg 61 (1990) 272-279
18. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F: One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br. J. Surg. 78 (1991) 797-801.
19. van Ooijen B, Wiggers T, Meijer S, van der Heijde M N, Sloof M J H, van de Velde C J H et al.: Hepatic resection for colorectal metastases in the Netherlands - a multiinstitutional 10-year-study. Cancer 70 (1991) 28-34
20. Steele G Jr, Bleday R, Mayer R J, Lindblad A, Petrelli N, Weaver D: A retrospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J. Clin. Oncol. 9 (1991) 1105-1112
21. Nordlinger B, Guiguet M, Vaillant J C, Balladur P, Boudjema K, Bachellier P et al.: Surgical resection of colorectal carcinoma metastatic to the liver. Cancer 77 (1996) 1254-1262
22. EORTC, NCIC CTG, G.I.V.I.O. (1994): Phase III clinical trial of chemotherapy with 5-fIuorouracil and L-leucovorin following potentially curative resection of liver or lung metastases from colorectal cancer. NCIC CTG Protocol Number CO.7, EORTC Protocol Number 40923, GIVIO Protocol Number CO.3.